Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Liabilities from Discontinued Operations (2024 - 2025)

Standard Biotools (LAB) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 22214000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 22214000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 22214000.0, a N/A change, with the full-year FY2024 number at 6779000.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations was 22214000.0 for Q3 2025 at Standard Biotools, up from 17984000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 22214000.0 in Q3 2025 to a low of 6779000.0 in Q4 2024.